收藏切换
Real-world adverse event profile of trabectedin: A signal mining and spatiotemporal analysis based on FAERS database
收藏切换
Bowen ZHANG1, Ludan ZHANG1, Hongrui CHEN1, Chunxiao LYU1, Yunlong LIU1, Yang LUO2, Aruhan DONG2, Zhuting LI2, Yuhong HUANG1, Ruihua WANG1
Journal of Army Medical University | 2025, 47(19) : 2425 - 2436
Less
收藏切换
Journal of Army Medical University | 2025, 47(19): 2425-2436
• Think Tank for Public Health •
Real-world adverse event profile of trabectedin: A signal mining and spatiotemporal analysis based on FAERS database
Full
Bowen ZHANG1, Ludan ZHANG1, Hongrui CHEN1, Chunxiao LYU1, Yunlong LIU1, Yang LUO2, Aruhan DONG2, Zhuting LI2, Yuhong HUANG1, Ruihua WANG1
Affiliations
  • 1Center for Clinical Pharmacology, the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300250,China
  • 2Department of Oncology, the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300250,China
Published: 2025-10-15 doi: 10.16016/j.2097-0927.202506027
Outline
收藏切换
Objective

To analyze the characteristics of real-world adverse drug events (ADEs) of trabectedin based on the FDA Adverse Event Reporting System (FAERS) database in order to provide references for clinical drug safety management.

Methods

A total of 1 349 trabectedin-related reports were extracted from the FAERS database from Q1 2007 to Q4 2024. Using the MedDRA coding classification system for system organ class (SOC) and preferred term (PT), signal detection was performed through 4 proportional imbalance methods, including reporting odds ratio (ROR) and proportional reporting ratio (PRR). Subgroup analyses by gender, age, and temporal trends were also conducted.

Results

Hematological and lymphatic system disorders and hepatobiliary system disorders were the primary SOCs involved. High-frequency PTs included neutropenia (123 cases) and anemia (117 cases). Eight potential ADEs that have not been listed in the drug product instruction were identified. The median onset time of ADEs was 21 d, showing an early failure pattern, with differences observed by gender (females more prone to hematological toxicity) and age (elderly more susceptible to febrile neutropenia).

Conclusion

Trabectedin requires close attention to hematological toxicity, hepatotoxicity, and newly identified multi-system potential risks. Clinically, monitoring should be strengthened based on time windows and population characteristics to optimize drug regimens. Countermeasure It is recommended to strengthen the full cycle monitoring of anti-tumor drugs, standardize the reporting of adverse reactions, and establish a multi-departmental collaborative research platform.

trabectedin  /  FDA Adverse Event Reporting System  /  pharmacovigilance  /  signal mining
张博文, 张露丹, 陈竑瑞, 吕春晓, 刘云龙, 罗洋, 董阿茹汗, 李竹庭, 黄宇虹, 王瑞华. 曲贝替定的真实世界不良事件风险特征:一项基于FAERS数据库的信号挖掘与时空分析. 陆军军医大学学报, 2025 , 47 (19) : 2425 -2436 . DOI: 10.16016/j.2097-0927.202506027
Bowen ZHANG, Ludan ZHANG, Hongrui CHEN, Chunxiao LYU, Yunlong LIU, Yang LUO, Aruhan DONG, Zhuting LI, Yuhong HUANG, Ruihua WANG. Real-world adverse event profile of trabectedin: A signal mining and spatiotemporal analysis based on FAERS database[J]. Journal of Army Medical University, 2025 , 47 (19) : 2425 -2436 . DOI: 10.16016/j.2097-0927.202506027
Year 2025 volume 47 Issue 19
11
2
Cite this Article
BibTeX
Article Info
doi: 10.16016/j.2097-0927.202506027
  • Receive Date:2025-06-10
  • Online Date:2026-10-30
  • Published:2025-10-15
Article Data
Affiliations
History
  • Received:2025-06-10
  • Revised:2025-09-09
Affiliations
    1Center for Clinical Pharmacology, the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300250,China
    2Department of Oncology, the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300250,China
References
Share
https://castjournals.cast.org.cn/joweb/ljjydxxb/EN/10.16016/j.2097-0927.202506027
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT